GIC Private Limited Reduces Stake in Entero Healthcare Solutions to 3.14%
The Government of Singapore (GOS), through GIC, has sold 9,846 equity shares of Entero Healthcare Solutions Limited on August 11, 2025. This transaction reduced GIC's shareholding from 3.16% to 3.14% of the company's total share capital. GIC's stake has been gradually decreasing since February 2024, when it held a 5.16% stake. The disclosure was made in compliance with SEBI regulations.
Entero Healthcare Solutions Limited reported robust Q1 financial results with consolidated revenue reaching ₹14,038.19 million and net profit of ₹302.32 million. The company acquired a 70% stake in Ramson Medical Distributors and increased its shareholding in Peerless Biotech to 76%. The deadline for acquiring equity shares in four pharma companies has been extended to November 30. Three non-operating subsidiaries were struck off during the quarter.
27May 25
Entero Healthcare Solutions Reports Strong Q4 Performance with Significant EBITDA and Profit Growth
Entero Healthcare Solutions announced impressive Q4 financial results. EBITDA surged 69.20% to ₹489.00 crore, with EBITDA margin improving to 3.65%. Consolidated net profit increased 22.40% to ₹257.00 crore. Revenue grew 29.60% to ₹13,400.00 crore. The company's performance demonstrates operational efficiency and strong market position in the healthcare sector.
19Mar 25
Entero Healthcare Solutions Expands Digital Footprint with Aayu Chemist and Medcords Acquisition
Entero Healthcare Solutions has acquired the Aayu Chemist app and Medcords platform from Medcords Healthcare as part of its new 'HealthEdge' programme. This initiative aims to digitally empower retail chemists across India with features like inventory management, expiry management, online store management, and financial support. The acquisition is expected to strengthen Entero's market position, which currently serves over 86,200 retail pharmacies and 3,200 hospitals across 492 districts in India.
06Mar 25
Entero Healthcare Solutions Boosts Stake in Getwell Medicare with ₹170 Crore Investment
Entero Healthcare Solutions Limited has increased its stake in subsidiary Getwell Medicare Solutions Private Limited from 85% to 95.20% through a ₹170 crore investment in equity shares on a rights basis. This strategic move expands Entero's shareholding from 68,00,000 to 2,38,00,000 equity shares, strengthening its position in the healthcare sector.